News and Announcements
MediKane Annual Update 2015; Featured on 7 News & Secures 630k in Funding
- Published December 16, 2015 4:02PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
MediKane’s flagship product was featured on 7 National News in September which increased sales dramatically and assisted acquiring funding of $630,000.
This increased demand required the appointment of a sales manager and two additional directors including a CFO and Marketing. Multiple sales contracts were finalised with pharmaceutical companies, Diabetes Australia, three Australian distributors plus China and New Zealand distributors.
A new hospital product was finalised for distribution through health practitioners and MediKane continues to present at Diabetes Educator webinars, international diabetes conferences, and advertise in diabetes key magazines which deliver sales.
MediKane is growing strongly.
Investors contact [email protected].
ABOUT MEDIKANE
MediKane sells high margin products into the gut health and diabetes markets.
The company is at early stage commercialisation and has products selling in Australia and China. The products have been independently demonstrated as being effective by the Royal Melbourne Hospital, medical clinics and diabetes organisations. The products have multiple paths to market, initially via health care practices including medical clinics and naturopaths, and shortly hospitals, dieticians and various diabetes organisations.